PLAT and stroke disorder: Approximately 7% of diagnosed ischemic stroke events currently receive t-PA therapy [13], due mostly to the public’s lack of knowledge about the treatment and the inability to identify and respond appropriately to stroke symptoms when they occur [14,15].